Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;138(1):325-35.e1-2.
doi: 10.1053/j.gastro.2009.08.066. Epub 2009 Sep 10.

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

Golo Ahlenstiel  1 , Rachel H Titerence, Christopher Koh, Birgit Edlich, Jordan J Feld, Yaron Rotman, Marc G Ghany, Jay H Hoofnagle, T Jake Liang, Theo Heller, Barbara Rehermann
Affiliations

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

Golo Ahlenstiel et al. Gastroenterology. 2010 Jan.

Abstract

Background & aims: Patients with chronic hepatitis C virus (HCV) infection display great variability in disease activity and progression. Although virus-specific adaptive immune responses have been characterized extensively and found to be impaired in chronic hepatitis C, the role of innate immune responses in disease activity and progression of chronic hepatitis C is not well understood.

Methods: We studied 42 HCV-infected patients and 12 healthy uninfected controls.

Results: We found an increased frequency of natural killer (NK) cells expressing tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), NKp44, NKG2C, and CD122 in chronic hepatitis C as compared with healthy controls (P < .05 for all markers) and stronger activation of NK cells in the liver than in the blood (P < .05). This NK cell phenotype was associated with polarization of NK cell function toward CD107a expression as a marker of degranulation, but with not increased interferon (IFN)-gamma production of CD56(dim) NK cells. The polarized NK cell phenotype correlated with alanine aminotransferase levels (r(2) = 0.312, P = .03). To investigate whether in vivo exposure of NK cells to HCV-induced type I IFN was causing this NK cell phenotype, peripheral blood mononuclear cells from 10 healthy controls and 8 HCV-infected patients were stimulated in the presence of IFN-alfa, which resulted in increased NK cell expression of TRAIL and CD107a (P < .001), but not IFN-gamma.

Conclusions: Collectively, these results describe a polarized NK cell phenotype induced by chronic exposure to HCV-induced IFN-alfa. This phenotype may contribute to liver injury through TRAIL expression and cytotoxicity, whereas the lacking increase in IFN-gamma production may facilitate the inability to clear HCV.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Multicolor flow cytometry to analyze NK cells in PBMC
(A) Gating strategy. (B-C) Representative dot plots showing the expression of cell surface markers on NK cells from healthy controls (B) and chronic HCV patients (C).
Fig. 2
Fig. 2. Phenotype of peripheral blood NK cells
Frequency (A) and MFI (B) of NK cells displaying the indicated surface markers in the blood of patients with chronic HCV infection and healthy, uninfected controls. Horizontal lines indicate the mean. n.s., not significant.
Fig. 3
Fig. 3. Comparison of NK cell phenotypes in blood and liver in chronic hepatitis C
Frequency and MFI of CD3-CD56+ NK cells (A-B), CD3-CD56dim NK cells (C-D) and CD3-CD56bright NK cells (E-F) with the indicated surface markers in blood and liver of patients with chronic HCV infection.
Fig. 4
Fig. 4. NK cell degranulation, a marker for cytotoxicity, correlates to liver injury in chronic hepatitis C
(A, B) The frequency of degranulating (CD107a+) NK cells within all CD3-CD56+ NK cells (left panel), the CD3-CD56dim NK cell subset (middle panel) and the CD3-CD56brightNK cell subset (right panel) is higher in HCV-infected patients with elevated ALT levels than in those with normal ALT levels. NK cells were exposed to MHC-negative K562 cells (A) or to MHC-negative K562 cells in the presence of IL-12 and IL-15 (B) to induce degranulation. (C) The frequency of degranulating (CD107a+) NK cells within all CD3-CD56+ NK cells (left panel) and within the CD3-CD56dim NK cell subset (right panel) correlates to ALT levels. Shaded areas indicate the range of normal (< 41 U/l) ALT levels. Horizontal lines indicate the mean.
Fig. 5
Fig. 5. NK cell IFN-γ secretion does not increase in patients with chronic hepatitis C
The frequency of IFN-γ-producing NK cells within all CD3-CD56+ NK cells (left panel), the CD3-CD56dim NK cell subset (middle panel) and the CD3-CD56bright NK cell subset (right panel) is not higher in HCV-infected patients with elevated ALT levels than in those with normal ALT levels. IFN-γ secretion was induced by stimulation with IL-12 and IL-15 (A) or with IL-12 and IL-18 (B). Only significant p-values (<0.05) are indicated. Horizontal lines indicate the mean.
Fig. 6
Fig. 6. NK cells of healthy, uninfected control subjects upregulate markers of cytotoxicity (CD107a, TRAIL) but not IFN-γ-production after in vitro exposure to IFN-α
CD3-CD56dim (A, B) and CD3-CD56bright (C, D) NK cells increase TRAIL and CD107a expression (A, C) but not IFN-γ-production (B, D) after in vitro exposure to IFN-α. n.s., not significant.
Fig. 7
Fig. 7. NK cells of chronic HCV patients upregulate markers of cytotoxicity (CD107a, TRAIL) but not IFN-γ-production after in vitro exposure to IFN-α
CD3-CD56dim (A, B) and CD3-CD56bright (C, D) NK cells increase TRAIL and CD107a expression (A, C) but not IFN-γ-production (B, D) after in vitro exposure to IFN-α. n.s., not significant.
Fig. 8
Fig. 8. Model
Chronic exposure to HCV-induced IFN-α induces a polarized NK cell phenotype that contributes to liver inflammation due to increased cytotoxicity but not to viral clearance due to lack of IFN-γ production (see discussion for details).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5:215–29. - PubMed
    1. Urbani S, Amadei B, Fisicaro P, Pilli M, Missale G, Bertoletti A, Ferrari C. Heterologous T cell immunity in severe hepatitis C virus infection. J Exp Med. 2005;201:675–80. - PMC - PubMed
    1. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, Robbins G, Phillips R, Klenerman P, Walker BD. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 2000;191:1499–512. - PMC - PubMed
    1. Chang KM, Thimme R, Melpolder JJ, Oldach D, Pemberton J, Moorhead-Loudis J, McHutchison JG, Alter HJ, Chisari FV. Differential CD4 and CD8 T-cell responsiveness in hepatitis C virus infection. Hepatology. 2001;33:267–276. - PubMed
    1. Lauer GM, Barnes E, Lucas M, Timm J, Ouchi K, Kim AY, Day CL, Robbins GK, Casson DR, Reiser M, Dusheiko G, Allen TM, Chung RT, Walker BD, Klenerman P. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 2004;127:924–36. - PubMed

Publication types

MeSH terms

Substances